Research Article Details
| Article ID: | A51132 |
| PMID: | 35577653 |
| Source: | Nutrition |
| Title: | May Silymarin be selectively considered for nonalcoholic fatty liver disease without elevated transaminases? Comment re. "Impact of Silymarin in individuals with nonalcoholic fatty liver disease: a systematic review and meta-analysis". |
| Abstract: | |
| DOI: | 10.1016/j.nut.2022.111648 |
| Strategy ID | Therapy Strategy | Synonyms | Therapy Targets | Therapy Drugs |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Diseases ID | DO ID | Disease Name | Definition | Class |
|---|
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress | |
|---|---|---|---|---|---|---|---|
| D336 | Silymarin | Biological drug | DB14375 | -- | Antiviral; Antioxidant; Antifibrotic; Anti-inflammatory | Under clinical trials | Details |
| D316 | S-adenosyl-L-methionine | Chemical drug | DB00118 | GNMT cofactor | Antiviral | Under clinical trials | Details |